2-74514845-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_016170.5(TLX2):c.39C>A(p.His13Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,612,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016170.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TLX2 | NM_016170.5 | c.39C>A | p.His13Gln | missense_variant | 1/3 | ENST00000233638.8 | NP_057254.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TLX2 | ENST00000233638.8 | c.39C>A | p.His13Gln | missense_variant | 1/3 | 1 | NM_016170.5 | ENSP00000233638.6 | ||
TLX2 | ENST00000621092.1 | c.11+611C>A | intron_variant | 1 | ENSP00000482690.1 | |||||
TLX2 | ENST00000497238.1 | n.522-177C>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000242 AC: 6AN: 247668Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134934
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460570Hom.: 0 Cov.: 34 AF XY: 0.00000826 AC XY: 6AN XY: 726688
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.39C>A (p.H13Q) alteration is located in exon 1 (coding exon 1) of the TLX2 gene. This alteration results from a C to A substitution at nucleotide position 39, causing the histidine (H) at amino acid position 13 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at